Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term:urinary bladder cancer
go back to main search page
Accession:DOID:11054 term browser browse the term
Definition:An urinary system cancer that results_in malignant growth located_in the urinary bladder. (DO)
Synonyms:exact_synonym: bladder cancer;   bladder cancers;   cancer of bladder;   cancer of the bladder;   malignant tumor of urinary bladder;   tumor of the bladder
 narrow_synonym: BLADDER CANCER, TRANSITIONAL CELL, SOMATIC
 primary_id: MESH:D001749
 alt_id: MIM:109800
 xref: GARD:12210;   ICD10CM:C67;   ICD9CM:188;   MONDO:0001187;   NCI:C2901;   NCI:C9334
For additional species annotation, visit the Alliance of Genome Resources.


show annotations for term's descendants           Sort by:
urinary bladder cancer term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Yt blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:29644616 NCBI chr 7:92,915,065...92,922,079
Ensembl chr 7:106,311,944...106,318,184 		JBrowse link
G AKT1 AKT serine/threonine kinase 1 disease_progression ISO protein:increased expression:urinary bladder
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:18190825 PMID:36115647 RGD:2291891 NCBI chr14:85,417,229...85,444,722
Ensembl chr14:105,208,128...105,236,756 		JBrowse link
G ALOX12 arachidonate 12-lipoxygenase, 12S type ISO protein:increased expression:urinary bladder RGD PMID:14532840 RGD:2315608 NCBI chr17:7,026,839...7,041,598
Ensembl chr17:7,014,591...7,029,602 		JBrowse link
G AMACR alpha-methylacyl-CoA racemase severity ISO RGD PMID:18648853 RGD:2315629 NCBI chr 5:76,336,631...76,358,724
Ensembl chr 5:81,687,891...81,742,003 		JBrowse link
G AMFR autocrine motility factor receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9241080 NCBI chr16:36,647,792...36,711,782
Ensembl chr16:55,780,633...55,843,744 		JBrowse link
G ANG angiogenin ISO protein:increased expression:urine
protein:increased expression:plasma		 RGD PMID:15329320 PMID:15912517 RGD:2325700 RGD:2325704 NCBI chr14:1,548,693...1,558,528
Ensembl chr14:19,614,950...19,615,393 		JBrowse link
G ANKFY1 ankyrin repeat and FYVE domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr17:4,217,880...4,316,017
Ensembl chr17:4,209,250...4,307,328 		JBrowse link
G ANPEP alanyl aminopeptidase, membrane ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr15:68,479,349...68,509,238
Ensembl chr15:87,681,826...87,703,713 		JBrowse link
G ANXA2R annexin A2 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 5:67,335,346...67,338,556
Ensembl chr 5:72,383,027...72,383,608 		JBrowse link
G APEX1 apurinic/apyrimidinic endodeoxyribonuclease 1 susceptibility ISO RGD PMID:19041121 RGD:2315660 NCBI chr14:1,329,745...1,332,315
Ensembl chr14:19,381,911...19,384,542 		JBrowse link
G APOBEC3B apolipoprotein B mRNA editing enzyme catalytic subunit 3B ISO CTD Direct Evidence: marker/mechanism CTD PMID:23852168 PMID:27643540 NCBI chr22:19,892,548...19,902,455
Ensembl chr22:37,711,588...37,721,265 		JBrowse link
G AQP3 aquaporin 3 (Gill blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:22306368 NCBI chr 9:33,221,989...33,228,469
Ensembl chr 9:34,032,983...34,039,438 		JBrowse link
G AREG amphiregulin disease_progression ISO mRNA:increased expression:urinary bladder RGD PMID:11133810 PMID:11507076 RGD:2292661 RGD:2292662 NCBI chr 4:49,737,191...49,747,013
Ensembl chr 4:55,570,299...55,580,142 		JBrowse link
G ARID1A AT-rich interaction domain 1A ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:25741868 PMID:32888375 PMID:34942405 NCBI chr 1:25,960,868...26,047,057
Ensembl chr 1:27,018,616...27,103,239 		JBrowse link
G AS3MT arsenite methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:22747749 PMID:29669044 PMID:29859237 PMID:32539094 NCBI chr10:99,470,026...99,502,829
Ensembl chr10:102,933,671...102,964,692 		JBrowse link
G ASAP1 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 8:126,688,608...127,080,662
Ensembl chr 8:129,418,796...130,021,261 		JBrowse link
G ASXL2 ASXL transcriptional regulator 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr2A:25,730,155...25,880,089
Ensembl chr2A:25,832,527...25,973,659 		JBrowse link
G ATM ATM serine/threonine kinase ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:8755918 PMID:9043869 PMID:9450874 PMID:9463314 PMID:9497252 More... NCBI chr11:103,109,979...103,256,405
Ensembl chr11:106,584,228...106,727,041 		JBrowse link
G ATP5F1D ATP synthase F1 subunit delta ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340
G ATP5MC2 ATP synthase membrane subunit c locus 2 ISO DNA:hypermethylation:promoter RGD PMID:26929985 RGD:14696811 NCBI chr12:35,078,290...35,089,480 JBrowse link
G AURKA aurora kinase A disease_progression ISO mRNA, protein:increased expression:urinary bladder RGD PMID:18485461 RGD:2293871 NCBI chr20:52,707,757...52,730,579
Ensembl chr20:53,994,881...54,017,339 		JBrowse link
G AXIN1 axin 1 susceptibility ISO DNA:SNPs:5'utr: (rs12921862, rs1805105, rs370681) (human) RGD PMID:31143301 RGD:150527861 Ensembl chr16:278,239...337,891 JBrowse link
G BAP1 BRCA1 associated deubiquitinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231345 NCBI chr 3:52,344,067...52,352,187
Ensembl chr 3:53,573,785...53,581,943 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator ISO RGD PMID:18452128 RGD:2296023 NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468 		JBrowse link
G BCL2 BCL2 apoptosis regulator severity ISO CTD Direct Evidence: marker/mechanism
DNA:hypermethylation:promoter		 RGD
CTD		 PMID:18094410 PMID:18342927 PMID:36115647 RGD:2292910 RGD:2293014 NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100 		JBrowse link
G BCL2L1 BCL2 like 1 disease_progression ISO RGD PMID:18342927 RGD:2292910 NCBI chr20:27,955,688...28,015,950
Ensembl chr20:29,088,055...29,146,585 		JBrowse link
G BIRC3 baculoviral IAP repeat containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12926068 NCBI chr11:97,269,778...97,290,112
Ensembl chr11:100,763,274...100,785,194 		JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 disease_progression ISO protein:increased expression:urinary bladder RGD PMID:17905101 PMID:18089718 RGD:2293094 RGD:2293096 NCBI chr17:72,292,332...72,303,493
Ensembl chr17:77,842,724...77,854,159 		JBrowse link
G BPTF bromodomain PHD finger transcription factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr17:61,759,241...61,917,343
Ensembl chr17:66,956,594...67,109,428 		JBrowse link
G BRCA1 BRCA1 DNA repair associated ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:7894493 PMID:8460636 PMID:8554067 PMID:8968102 PMID:9150154 More... NCBI chr17:14,197,946...14,279,064
Ensembl chr17:14,428,526...14,506,815 		JBrowse link
G BRCA2 BRCA2 DNA repair associated ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:2673801 PMID:8673091 PMID:8896551 PMID:8988179 PMID:9150172 More... NCBI chr13:13,574,422...13,658,967
Ensembl chr13:32,010,066...32,091,332 		JBrowse link
G C9H11orf65 chromosome 9 C11orf65 homolog ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:8755918 PMID:9450874 PMID:9463314 PMID:9497252 PMID:9733514 More... NCBI chr11:103,195,244...103,352,211
Ensembl chr11:106,670,277...106,817,886 		JBrowse link
G CA9 carbonic anhydrase 9 disease_progression ISO RGD PMID:14520462 RGD:2293197 NCBI chr 9:35,525,877...35,533,159
Ensembl chr 9:36,328,303...36,335,340 		JBrowse link
G CALHM1 calcium homeostasis modulator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr10:100,048,560...100,056,483
Ensembl chr10:103,511,873...103,517,376 		JBrowse link
G CASP3 caspase 3 disease_progression ISO RGD PMID:17267327 RGD:2298949 NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185 		JBrowse link
G CASP9 caspase 9 susceptibility
disease_progression		 ISO DNA:polymorphism, deletion: :1263A>G, 293del (human)
DNA:SNP:exon:p.Q221R (rs1052576) (human)		 RGD PMID:19252927 PMID:19412632 RGD:2315929 RGD:2315930 NCBI chr 1:14,630,659...14,662,865
Ensembl chr 1:15,624,666...15,656,266 		JBrowse link
G CAT catalase ISO CTD Direct Evidence: marker/mechanism CTD PMID:35764155 NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160 		JBrowse link
G CAV1 caveolin 1 severity ISO protein:increased expression:urinary bladder RGD PMID:12866378 RGD:2289110 NCBI chr 7:108,497,125...108,533,090
Ensembl chr 7:121,193,424...121,229,655 		JBrowse link
G CBX7 chromobox 7 severity ISO mRNA:decreased expression:urinary bladder (human) RGD PMID:18984978 RGD:9587361 NCBI chr22:20,037,529...20,059,459
Ensembl chr22:37,854,056...37,876,084 		JBrowse link
G CCND1 cyclin D1 ISO protein:increased expression:bladder
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:12372886 PMID:36115647 RGD:13602096 NCBI chr11:64,737,006...64,750,353 JBrowse link
G CCND3 cyclin D3 disease_progression ISO RGD PMID:16482499 RGD:2316012 NCBI chr 6:41,518,421...41,630,103
Ensembl chr 6:42,820,569...42,827,498 		JBrowse link
G CCNE1 cyclin E1 disease_progression
severity		 ISO protein:decreased expression:urinary bladder
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:16739882 PMID:18047954 PMID:20972438 PMID:27514407 RGD:2289267 RGD:2296035 NCBI chr19:26,739,285...26,751,630
Ensembl chr19:35,496,700...35,510,295 		JBrowse link
G CCNG1 cyclin G1 ISO mRNA:decreased expression:bladder (human) RGD PMID:27982046 RGD:151361200 NCBI chr 5:158,814,563...158,822,019
Ensembl chr 5:165,592,971...165,598,728 		JBrowse link
G CD40LG CD40 ligand treatment ISO RGD PMID:16361570 RGD:7248437 NCBI chr  X:125,776,138...125,788,820
Ensembl chr  X:136,042,849...136,058,202 		JBrowse link
G CD44 CD44 molecule (IN blood group) ISO RGD PMID:16321281 RGD:2289357 NCBI chr11:35,110,732...35,258,238
Ensembl chr11:34,985,634...35,079,009 		JBrowse link
G CD82 CD82 molecule disease_progression ISO protein:decreased expression:urinary bladder RGD PMID:14706010 PMID:17290345 RGD:2289391 RGD:2289401 NCBI chr11:44,526,010...44,581,560
Ensembl chr11:45,020,319...45,075,876 		JBrowse link
G CD9 CD9 molecule disease_progression ISO RGD PMID:14534881 RGD:2326207 NCBI chr12:6,327,783...6,366,083
Ensembl chr12:6,245,348...6,283,385 		JBrowse link
G CDC25A cell division cycle 25A ISO RGD PMID:17145867 RGD:2715645 NCBI chr 3:48,068,601...48,099,806
Ensembl chr 3:49,154,307...49,186,115 		JBrowse link
G CDC25B cell division cycle 25B disease_progression ISO RGD PMID:19383904 RGD:2739695 NCBI chr20:3,877,255...3,883,458
Ensembl chr20:3,626,107...3,645,179 		JBrowse link
G CDH1 cadherin 1 disease_progression ISO protein:decreased expression:urinary bladder
Protein:increased expression:cytoplasm
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:17167984 PMID:17520682 PMID:17760743 PMID:26901067 RGD:1599549 RGD:2289491 NCBI chr16:49,108,745...49,206,347
Ensembl chr16:68,502,584...68,596,488 		JBrowse link
G CDH13 cadherin 13 ISO DNA:hypermethylation:promoter RGD PMID:18094410 RGD:2293014 NCBI chr16:63,255,482...64,418,053
Ensembl chr16:82,883,184...83,808,996 		JBrowse link
G CDK1 cyclin dependent kinase 1 ISO RGD PMID:17145867 RGD:2715645 NCBI chr10:57,314,692...57,331,261
Ensembl chr10:59,647,993...59,664,434 		JBrowse link
G CDK4 cyclin dependent kinase 4 disease_progression ISO DNA:amplification
protein:increased expression:urinary bladder		 RGD PMID:11971182 PMID:16896691 RGD:2289144 RGD:2299056 NCBI chr12:31,174,446...31,178,597
Ensembl chr12:31,434,594...31,438,876 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar NCBI chr 6:36,241,405...36,250,032
Ensembl chr 6:37,436,990...37,445,599 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B disease_progression
susceptibility		 ISO RGD PMID:18027869 PMID:18334837 RGD:2293592 RGD:2293595 NCBI chr12:12,742,258...12,747,404
Ensembl chr12:13,120,306...13,125,541 		JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:7777061 PMID:7987387 PMID:8668202 PMID:8755727 PMID:8834170 More... NCBI chr 9:21,803,862...21,831,322 JBrowse link
G CDKN2B cyclin dependent kinase inhibitor 2B disease_progression ISO DNA:deletion
DNA:deletion:urinary bladder		 RGD PMID:15590562 PMID:16624482 RGD:2289696 RGD:7248757 NCBI chr 9:21,838,902...21,845,355
Ensembl chr 9:22,455,662...22,462,156 		JBrowse link
G CHD6 chromodomain helicase DNA binding protein 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr20:37,744,012...37,953,593
Ensembl chr20:38,839,685...38,999,501 		JBrowse link
G CHEK2 checkpoint kinase 2 susceptibility
treatment		 ISO DNA:mutations: :multiple RGD PMID:17918154 PMID:21396995 RGD:10401655 RGD:2289704 NCBI chr22:9,757,038...9,811,171 JBrowse link
G CLPTM1L CLPTM1 like ISO CTD Direct Evidence: marker/mechanism CTD PMID:19151717 Ensembl chr 5:1,361,571...1,388,415 JBrowse link
G COL6A3 collagen type VI alpha 3 chain ISO mRNA, protein:increased expression:bladder (human) RGD PMID:30066698 RGD:401900123 NCBI chr2B:124,554,478...124,644,482 JBrowse link
G COMT catechol-O-methyltransferase ISO protein:increased expression:urinary bladder, urine RGD PMID:15596044 RGD:2289726 NCBI chr22:2,704,015...2,731,326
Ensembl chr22:18,375,434...18,402,387 		JBrowse link
G CREBBP CREB binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr16:2,645,445...2,800,975
Ensembl chr16:3,820,519...3,974,206 		JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: therapeutic CTD PMID:7525883 PMID:17515069 NCBI chr17:17,271,074...17,273,493
Ensembl chr17:17,491,276...17,493,729 		JBrowse link
G CTNNA1 catenin alpha 1 disease_progression ISO RGD PMID:17760743 RGD:2289491 NCBI chr 5:134,134,944...134,313,239
Ensembl chr 5:140,261,883...140,438,547 		JBrowse link
G CTNNA3 catenin alpha 3 ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar NCBI chr10:62,388,454...64,177,116
Ensembl chr10:64,712,576...66,442,238 		JBrowse link
G CTNNB1 catenin beta 1 disease_progression ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder RGD
ClinVar		 PMID:10192393 PMID:10666372 PMID:17175927 PMID:26822237 RGD:2289829 NCBI chr 3:41,104,940...41,145,934
Ensembl chr 3:41,373,726...41,414,030 		JBrowse link
G CTSB cathepsin B ISO protein:increased activity:transitional cell carcinoma (human) RGD PMID:15183956 RGD:2315615 NCBI chr 8:7,333,498...7,359,264 JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22015448 NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083 		JBrowse link
G CXCR2 C-X-C motif chemokine receptor 2 ISO DNA:SNP RGD PMID:19252927 RGD:2315930 NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148 		JBrowse link
G CYP17A1 cytochrome P450 family 17 subfamily A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35764155 NCBI chr10:99,431,762...99,439,619
Ensembl chr10:102,896,376...102,901,514 		JBrowse link
G CYP19A1 cytochrome P450 family 19 subfamily A member 1 ISO RGD PMID:17406000 RGD:7257712 NCBI chr15:30,152,924...30,282,854
Ensembl chr15:48,486,688...48,521,554 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 no_association ISO DNA:polymorphisms: :3801T>C (human)
DNA:polymorphism: :2455A>G (human)		 RGD PMID:18200441 PMID:18979064 PMID:21990318 RGD:7257730 RGD:7257733 RGD:7257736 NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636 		JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 ISO RGD PMID:21990318 RGD:7257730 NCBI chr2A:38,087,863...38,096,529
Ensembl chr2A:38,851,000...38,859,824 		JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 ISO RGD PMID:16985032 RGD:6903918 NCBI chr10:91,547,865...91,598,918
Ensembl chr10:95,022,482...95,105,653 		JBrowse link
G CYP4B1 cytochrome P450 family 4 subfamily B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18713828 NCBI chr 1:46,107,787...46,127,162
Ensembl chr 1:47,462,178...47,481,502 		JBrowse link
G DAPK1 death associated protein kinase 1 ISO DNA:hypermethylation RGD PMID:12124340 RGD:734875 NCBI chr 9:58,628,872...58,836,205
Ensembl chr 9:86,681,953...86,887,958 		JBrowse link
G DNMT1 DNA methyltransferase 1 ISO protein:increased expression RGD PMID:14634451 RGD:2301220 NCBI chr19:9,681,847...9,745,334
Ensembl chr19:10,342,478...10,406,972 		JBrowse link
G DUSP1 dual specificity phosphatase 1 disease_progression ISO RGD PMID:17690186 RGD:2298694 NCBI chr 5:168,121,536...168,124,671
Ensembl chr 5:175,032,803...175,035,960 		JBrowse link
G E2F1 E2F transcription factor 1 disease_progression ISO mRNA:increased expression:bladder RGD PMID:20421545 RGD:13602004 NCBI chr20:29,963,083...29,973,860
Ensembl chr20:31,103,764...31,110,604 		JBrowse link
G EEF1E1 eukaryotic translation elongation factor 1 epsilon 1 disease_progression ISO protein:decreased expression:urothelium: RGD PMID:24917520 RGD:10401219 NCBI chr 6:7,911,807...7,940,918
Ensembl chr 6:8,192,997...8,222,056 		JBrowse link
G EGFR epidermal growth factor receptor disease_progression ISO protein:increased expression:urinary bladder
ClinVar Annotator: match by term: Malignant tumor of urinary bladder		 RGD
ClinVar		 PMID:16685269 PMID:18006009 PMID:28492532 RGD:2289943 RGD:2298502 NCBI chr 7:55,614,042...55,807,285
Ensembl chr 7:56,046,296...56,111,615 		JBrowse link
G ENO2 enolase 2 ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:17951193 PMID:22613180 RGD:2293738 NCBI chr12:7,043,807...7,053,178
Ensembl chr12:6,958,960...6,968,342 		JBrowse link
G EOMES eomesodermin ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 3:27,601,829...27,608,701
Ensembl chr 3:27,925,086...27,930,274 		JBrowse link
G EP300 E1A binding protein p300 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr22:21,986,467...22,076,921
Ensembl chr22:40,079,503...40,168,604 		JBrowse link
G EPHX1 epoxide hydrolase 1 disease_progression ISO DNA:SNPs RGD PMID:19252927 RGD:2315930 NCBI chr 1:201,271,366...201,306,635
Ensembl chr 1:206,272,866...206,307,581 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 disease_progression ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder RGD
ClinVar		 PMID:16685269 RGD:2298502 NCBI chr17:17,560,337...17,600,808
Ensembl chr17:17,777,434...17,805,862 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 disease_progression ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder RGD
ClinVar		 PMID:16685269 RGD:2298502 NCBI chr12:32,811,533...32,834,958
Ensembl chr12:33,063,434...33,084,994 		JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 disease_progression ISO protein:decreased expression:urinary bladder RGD PMID:16685269 PMID:18006009 RGD:2289943 RGD:2298502 NCBI chr2B:98,625,630...99,795,371
Ensembl chr2B:217,069,644...218,272,006 		JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit disease_progression ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder RGD
ClinVar		 PMID:9238033 PMID:11335038 PMID:19085937 PMID:19934020 PMID:25316812 More... RGD:11252208 NCBI chr19:42,298,927...42,319,816
Ensembl chr19:50,897,004...50,915,819 		JBrowse link
G ERCC4 ERCC excision repair 4, endonuclease catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:20062074 NCBI chr16:12,848,334...12,880,480
Ensembl chr16:14,272,417...14,304,496 		JBrowse link
G ESPL1 extra spindle pole bodies like 1, separase ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121792 NCBI chr12:35,460,500...35,486,794
Ensembl chr12:36,241,533...36,266,101 		JBrowse link
G ESR1 estrogen receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16712894 PMID:35764155 NCBI chr 6:149,507,599...149,918,523
Ensembl chr 6:154,317,002...154,631,551 		JBrowse link
G ESR2 estrogen receptor 2 severity ISO protein:increased expression:urinary bladder urothelium (human)
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:16700038 PMID:23612777 RGD:7364758 NCBI chr14:44,807,875...44,919,780
Ensembl chr14:63,064,402...63,131,303 		JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit ISO mRNA:increased expression:urinary bladder RGD PMID:21539681 RGD:126781700 NCBI chr 7:140,536,962...140,613,104
Ensembl chr 7:153,017,590...153,059,726 		JBrowse link
G F2 coagulation factor II, thrombin severity ISO protein:increased expression:urine RGD PMID:22236518 RGD:6893573 NCBI chr11:46,669,925...46,690,391
Ensembl chr11:47,227,891...47,249,157 		JBrowse link
G FANCA FA complementation group A ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:19237606 PMID:24121791 RGD:11344902 NCBI chr16:70,495,310...70,579,275
Ensembl chr16:90,163,950...90,245,147 		JBrowse link
G FAS Fas cell surface death receptor susceptibility ISO DNA:polymorphisms:promoter:-1377G>A,-670A>G
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:9070496 PMID:16538171 RGD:2290063 NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612 		JBrowse link
G FASLG Fas ligand susceptibility ISO DNA:polymorphisms:promoter:-844T>C RGD PMID:16538171 RGD:2290063 NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281 		JBrowse link
G FBXW8 F-box and WD repeat domain containing 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr12:114,487,476...114,607,384
Ensembl chr12:117,863,254...117,983,269 		JBrowse link
G FERMT2 FERM domain containing kindlin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21624607 NCBI chr14:33,453,983...33,547,721
Ensembl chr14:51,737,188...51,829,766 		JBrowse link
G FGF1 fibroblast growth factor 1 ISO RGD PMID:11908679 RGD:2290291 NCBI chr 5:137,949,100...138,054,553
Ensembl chr 5:144,056,387...144,078,001 		JBrowse link
G FGF2 fibroblast growth factor 2 ISO RGD PMID:11908679 RGD:2290291 NCBI chr 4:115,005,136...115,076,369
Ensembl chr 4:126,149,813...126,214,942 		JBrowse link
G FGFR2 fibroblast growth factor receptor 2 ISO DNA:hypermethylation, loss of heterozygosity, deletions:exon (human)
associated with Acrocephalosyndactylia/Apert Syndrome (MeSH:D000168); DNA:transversion:cds:758C>G amino acid P253R		 RGD PMID:10602477 PMID:16969861 RGD:2289664 RGD:2301193 NCBI chr10:118,055,854...118,175,440
Ensembl chr10:121,469,735...121,588,815 		JBrowse link
G FGFR3 fibroblast growth factor receptor 3 severity
disease_progression		 ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder | ClinVar Annotator: match by term: Urinary bladder cancer
DNA:mutations
protein:increased expression:urinary bladder		 OMIM
ClinVar
RGD		 PMID:1908846 PMID:7647778 PMID:7649548 PMID:7670477 PMID:7702086 More... RGD:2301223 RGD:2301224 RGD:2301225 NCBI chr 4:1,933,172...1,948,742
Ensembl chr 4:1,843,774...1,861,692 		JBrowse link
G FHIT fragile histidine triad diadenosine triphosphatase ISO associated with Schistosomiasis;DNA:hypermethylation:urinary bladder
DNA:hypermethylation:promoter:hypermethylation found in 16/98 (16%) of tumors, associated with poor survival
protein:decreased expression:urinary bladder		 RGD PMID:11751381 PMID:15154012 PMID:15591090 RGD:2289897 RGD:2301232 RGD:2301233 NCBI chr 3:59,670,777...61,177,974 JBrowse link
G FN1 fibronectin 1 ISO protein:increased expression:urine RGD PMID:20012564 RGD:7205680 NCBI chr2B:102,623,568...102,698,747
Ensembl chr2B:221,208,431...221,284,003 		JBrowse link
G GGH gamma-glutamyl hydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19815704 NCBI chr 8:59,547,821...59,571,523
Ensembl chr 8:61,222,194...61,246,252 		JBrowse link
G GLI1 GLI family zinc finger 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20179202 NCBI chr12:31,453,759...31,466,194
Ensembl chr12:31,710,057...31,722,473 		JBrowse link
G GPX1 glutathione peroxidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15247771 PMID:35764155 NCBI chr 3:49,280,038...49,281,455
Ensembl chr 3:50,360,947...50,361,826 		JBrowse link
G GSK3B glycogen synthase kinase 3 beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:36115647 NCBI chr 3:116,943,205...117,215,001
Ensembl chr 3:123,861,379...124,126,771 		JBrowse link
G GSTM1 glutathione S-transferase mu 1 susceptibility ISO DNA:deletion: : (human)
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:18505952 PMID:18544563 PMID:20972438 RGD:6906879 Ensembl chr 1:127,979,238...128,010,411 JBrowse link
G GSTO2 glutathione S-transferase omega 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22306368 NCBI chr10:100,868,109...100,901,013
Ensembl chr10:104,326,175...104,357,604 		JBrowse link
G GSTP1 glutathione S-transferase pi 1 ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:urinary bladder		 CTD
RGD		 PMID:7729958 PMID:9111193 PMID:12500666 PMID:18544563 PMID:21213404 More... RGD:10401939 RGD:6906879 RGD:6906883 NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472 		JBrowse link
G GSTZ1 glutathione S-transferase zeta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22306368 NCBI chr14:57,874,184...57,901,397
Ensembl chr14:77,075,814...77,086,530 		JBrowse link
G HDAC4 histone deacetylase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21507255 NCBI chr2B:126,287,745...126,649,815
Ensembl chr2B:245,123,061...245,427,054 		JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:36115647 NCBI chr14:42,295,691...42,348,478
Ensembl chr14:60,552,374...60,604,885 		JBrowse link
G HK1 hexokinase 1 treatment ISO RGD PMID:23893687 RGD:11353960 NCBI chr10:65,786,940...65,870,204
Ensembl chr10:68,289,288...68,401,045 		JBrowse link
G HMBS hydroxymethylbilane synthase ISO urinary bladder transitional cell carcinoma; mRNA:decreased expression:tumor:in matched malignant and non-malignant sample pairs (p = 0.008) RGD PMID:16600798 RGD:2301681 NCBI chr11:113,923,004...113,931,732
Ensembl chr11:117,852,295...117,860,757 		JBrowse link
G HMGB3 high mobility group box 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30639441 NCBI chr  X:140,632,163...140,639,774 JBrowse link
G HMGN5 high mobility group nucleosome binding domain 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22109888 NCBI chr  X:70,180,585...70,268,545 JBrowse link
G HOXA9 homeobox A9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26332997 NCBI chr 7:27,806,942...27,810,304
Ensembl chr 7:27,405,931...27,409,984 		JBrowse link
G HRAS HRas proto-oncogene, GTPase disease_progression ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder | ClinVar Annotator: match by term: Urinary bladder cancer OMIM
ClinVar
RGD		 PMID:2999610 PMID:3537694 PMID:6092966 PMID:6330729 PMID:7177195 More... RGD:2314833 NCBI chr11:537,488...540,810
Ensembl chr11:568,305...571,078 		JBrowse link
G HSPA1A heat shock protein family A (Hsp70) member 1A treatment ISO RGD PMID:19914824 RGD:7242743 NCBI chr 6:31,476,710...31,491,411 JBrowse link
G ICAM1 intercellular adhesion molecule 1 ISO protein:increased expression:serum: RGD PMID:7686390 RGD:11520780 NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605 		JBrowse link
G IFNB1 interferon beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:2297754 NCBI chr 9:20,884,742...20,886,317 JBrowse link
G IFNG interferon gamma treatment ISO protein:decreased expression:serum RGD PMID:11219496 PMID:22906662 RGD:6893349 RGD:8157619 NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829 		JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19415693 NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177 		JBrowse link
G IGFBP3 insulin like growth factor binding protein 3 ISO protein:decreased expression:plasma:level significantly lower in cases than controls (p<0.01), highest quartile levels associated with reduced risk (OR=0.38)
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:12544349 PMID:21347663 RGD:2290028 NCBI chr 7:46,564,234...46,573,145 JBrowse link
G IGFBP5 insulin like growth factor binding protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr2B:103,932,983...103,956,475
Ensembl chr2B:222,534,967...222,558,432 		JBrowse link
G IGSF21 immunoglobin superfamily member 21 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 1:17,063,522...17,336,389
Ensembl chr 1:18,116,451...18,387,611 		JBrowse link
G IL1B interleukin 1 beta disease_progression ISO mRNA:increased expression:urinary bladder tumor (human) RGD PMID:21308147 RGD:7175327 NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424 		JBrowse link
G IL1RN interleukin 1 receptor antagonist susceptibility ISO DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
DNA:repeats:intron:IVS2+914_1000dup multiple (human)		 RGD PMID:16698387 PMID:19489682 RGD:6907081 RGD:6907367 NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839 		JBrowse link
G IL2 interleukin 2 treatment ISO CTD Direct Evidence: therapeutic CTD
RGD		 PMID:1949363 PMID:3262172 PMID:3495671 RGD:8663471 NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984 		JBrowse link
G INPP4B inositol polyphosphate-4-phosphatase type II B ISO CTD Direct Evidence: marker/mechanism CTD PMID:29415082 NCBI chr 4:134,405,934...135,213,851
Ensembl chr 4:145,706,307...146,141,029 		JBrowse link
G ISL1 ISL LIM homeobox 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26332997 NCBI chr 5:62,635,095...62,650,141
Ensembl chr 5:64,252,715...64,264,674 		JBrowse link
G JAK2 Janus kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:36115647 NCBI chr 9:4,820,303...4,971,867
Ensembl chr 9:5,006,271...5,156,626 		JBrowse link
G JUP junction plakoglobin disease_progression
severity		 ISO protein:decreased expression:tumor:significant association with tumor grade and stage (p < 0.001)
DNA, protein:mutations, increased expression:urinary bladder
protein:altered localization:tumor:loss of membrane expression associated with higher grade (p<0.05), higher stage (p<0.05), and poor survival (p<0.05)		 RGD PMID:9783980 PMID:11585741 PMID:17363521 RGD:2289818 RGD:2291880 RGD:2301748 NCBI chr17:15,527,115...15,559,251
Ensembl chr17:15,747,163...15,777,479 		JBrowse link
G KCNJ12 potassium inwardly rectifying channel subfamily J member 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34755307 NCBI chr17:30,190,240...30,233,740 JBrowse link
G KDM4A lysine demethylase 4A ISO mRNA:increased expression:urinary bladder (human) RGD PMID:23603248 RGD:9587435 NCBI chr 1:42,949,977...43,005,684
Ensembl chr 1:44,325,624...44,380,163 		JBrowse link
G KDM4B lysine demethylase 4B ISO mRNA, protein:increased expression:urinary bladder (human) RGD PMID:21930796 RGD:9587740 NCBI chr19:3,986,296...4,172,359
Ensembl chr19:4,977,413...5,116,113 		JBrowse link
G KDM5B lysine demethylase 5B ISO mRNA:increased expression:urinary bladder (human) RGD PMID:20226085 RGD:9587778 NCBI chr 1:178,323,073...178,406,608
Ensembl chr 1:182,622,425...182,702,994 		JBrowse link
G KDM6A lysine demethylase 6A ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:23076834 PMID:23913813 PMID:25741868 PMID:27777708 PMID:28492532 NCBI chr  X:37,313,000...37,548,630
Ensembl chr  X:45,127,382...45,362,029 		JBrowse link
G KDR kinase insert domain receptor severity ISO protein::tumor:expression in >50% of non-endothelial cells associated with increased survival (p=0.0119) RGD PMID:12215294 PMID:12940780 RGD:2291949 RGD:2301758 NCBI chr 4:68,813,894...68,861,018
Ensembl chr 4:75,377,375...75,427,109 		JBrowse link
G KISS1 KiSS-1 metastasis suppressor ISO mRNA:decreased expression:tumor:loss of expression in all invasive tumors vs normal urothelium, ecpression also associated with histological stage and overall survival RGD PMID:12547718 RGD:2292136
G KIT KIT proto-oncogene, receptor tyrosine kinase ISO urinary bladder small cell carcinoma; protein:increased expression:tumor:14/52 (27%) positive (>10% staining) RGD PMID:15502806 RGD:2292430 NCBI chr 4:69,199,543...69,282,323
Ensembl chr 4:75,761,946...75,844,473 		JBrowse link
G KLF5 KLF transcription factor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27514407
G KMT2A lysine methyltransferase 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr11:113,273,198...113,364,404
Ensembl chr11:117,204,820...117,290,100 		JBrowse link
G KMT2C lysine methyltransferase 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr 7:143,714,716...144,016,188
Ensembl chr 7:155,862,610...156,081,043 		JBrowse link
G KMT2D lysine methyltransferase 2D ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr12:39,689,463...39,731,904
Ensembl chr12:40,575,083...40,608,661 		JBrowse link
G KRAS KRAS proto-oncogene, GTPase ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Bladder cancer, transitional cell, somatic | ClinVar Annotator: match by term: Malignant tumor of urinary bladder | ClinVar Annotator: match by term: Urinary bladder cancer OMIM
ClinVar		 PMID:1553789 PMID:1875403 PMID:6695174 PMID:7773929 PMID:8439212 More... NCBI chr12:61,062,689...61,108,524
Ensembl chr12:63,679,293...63,724,335 		JBrowse link
G KRT16 keratin 16 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20186695 NCBI chr17:15,704,348...15,707,328
Ensembl chr17:15,922,924...15,929,437 		JBrowse link
G KRT5 keratin 5 ISO RGD PMID:7507402 RGD:1600196 NCBI chr12:36,243,221...36,249,573
Ensembl chr12:37,021,432...37,025,105 		JBrowse link
G LAMA2 laminin subunit alpha 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 6:126,672,013...127,307,870
Ensembl chr 6:130,781,781...131,415,337 		JBrowse link
G LIG1 DNA ligase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:8631603 NCBI chr19:45,056,737...45,110,867
Ensembl chr19:53,706,778...53,761,088 		JBrowse link
G LOC100969764 sulfotransferase 1A1 ISO DNA:SNP:CDS:reduced risk associated with the His allele of the R213H polymorphism in women, particularly in those with no history of smoking RGD PMID:14643027 RGD:1581442
G LOC100972354 interferon alpha-2 ISO CTD Direct Evidence: therapeutic CTD PMID:17172406 NCBI chr 9:21,245,017...21,246,210
Ensembl chr 9:21,863,062...21,863,736 		JBrowse link
G LOC100986475 metallothionein-2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:7729958 PMID:16565513 NCBI chr16:36,894,853...36,895,826
Ensembl chr16:56,007,922...56,028,093 		JBrowse link
G LOC100988637 olfactory receptor 8S1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr12:40,222,761...40,225,550
Ensembl chr12:41,099,081...41,101,968 		JBrowse link
G LOC100990437 NADPH--cytochrome P450 reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:8631603 NCBI chr 7:68,035,021...68,105,934
Ensembl chr 7:82,364,418...82,437,530 		JBrowse link
G LOXL1 lysyl oxidase like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17456585 NCBI chr15:52,835,675...52,861,324 JBrowse link
G LOXL4 lysyl oxidase like 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17456585 NCBI chr10:94,861,187...94,881,784
Ensembl chr10:98,357,322...98,372,691 		JBrowse link
G LRRC56 leucine rich repeat containing 56 ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Urinary bladder cancer
ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder | ClinVar Annotator: match by term: Urinary bladder cancer		 ClinVar PMID:2999610 PMID:3537694 PMID:6092966 PMID:6330729 PMID:7177195 More... NCBI chr11:514,227...559,838
Ensembl chr11:575,495...588,750 		JBrowse link
G MAP2K4 mitogen-activated protein kinase kinase 4 ISO RGD PMID:15665277 RGD:2306057 NCBI chr17:39,497,105...39,622,331
Ensembl chr17:44,248,857...44,359,909 		JBrowse link
G MAP2K7 mitogen-activated protein kinase kinase 7 ISO mRNA:splice variant:exon 2: (human) RGD PMID:32601196 RGD:155230826 NCBI chr19:7,205,124...7,215,776
Ensembl chr19:8,057,598...8,066,512 		JBrowse link
G MAPK15 mitogen-activated protein kinase 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 8:140,468,365...140,474,604
Ensembl chr 8:143,481,567...143,492,859 		JBrowse link
G MDM2 MDM2 proto-oncogene severity ISO mRNA:increased expression:bladder RGD PMID:27798881 RGD:13602098 NCBI chr12:66,322,340...66,357,010
Ensembl chr12:69,102,084...69,133,278 		JBrowse link
G MGMT O-6-methylguanine-DNA methyltransferase susceptibility ISO DNA:polymorphisms:cds:p.L53L, p.L84F (human) RGD PMID:15885889 RGD:2317672 NCBI chr10:126,059,701...126,365,850
Ensembl chr10:130,305,485...130,609,422 		JBrowse link
G MKI67 marker of proliferation Ki-67 ISO protein:increased expression:urinary bladder RGD PMID:20367636 RGD:2317708 NCBI chr10:124,684,336...124,714,143
Ensembl chr10:128,936,037...128,962,555 		JBrowse link
G MLH1 mutL homolog 1 disease_progression ISO RGD PMID:15296997 RGD:2293518 NCBI chr 3:36,899,828...36,957,076
Ensembl chr 3:37,189,439...37,245,801 		JBrowse link
G MMP1 matrix metallopeptidase 1 severity ISO protein:increased expression:urine (human)
DNA:insertion:promoter:g.-1607insG (human)		 RGD PMID:11705862 PMID:17986285 RGD:7207077 RGD:7207140 NCBI chr11:97,730,545...97,739,190
Ensembl chr11:101,221,393...101,230,104 		JBrowse link
G MMP13 matrix metallopeptidase 13 ISO urinary bladder transitional-cell carcinomas; mRNA:increased expression:tumor:13/23 (52%) tumors vs no expression in normal urothelium, expression at the invading edge of tumors RGD PMID:11054671 RGD:2293609 NCBI chr11:97,890,811...97,902,778
Ensembl chr11:101,377,001...101,387,679 		JBrowse link
G MMP2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:17466450 PMID:30548095 RGD:2290395 NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279 		JBrowse link
G MMP9 matrix metallopeptidase 9 ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:17466450 PMID:30548095 RGD:2290395 NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129 		JBrowse link
G MPO myeloperoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14729580 NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111 		JBrowse link
G MRE11 MRE11 homolog, double strand break repair nuclease susceptibility ISO DNA:snp:3' utr:c.2501A>G rs2155209 (human)
ClinVar Annotator: match by term: Malignant tumor of urinary bladder		 RGD
ClinVar		 PMID:18638378 PMID:28492532 RGD:2317733 NCBI chr11:89,418,537...89,500,705
Ensembl chr11:92,918,549...92,985,966 		JBrowse link
G MSH2 mutS homolog 2 disease_progression ISO protein:decreased expression:urinary bladder
associated with Lynch syndrome
DNA:mutations: :multiple		 RGD PMID:18254781 PMID:18389386 PMID:22883484 PMID:26385421 RGD:126790557 RGD:126790580 RGD:2293502 RGD:2293503 NCBI chr2A:47,524,468...47,602,376
Ensembl chr2A:48,447,207...48,554,461 		JBrowse link
G MSH6 mutS homolog 6 disease_progression ISO protein:decreased expression:urinary bladder RGD PMID:18254781 RGD:2293503 NCBI chr2A:47,901,591...47,926,662
Ensembl chr2A:48,824,350...48,849,779 		JBrowse link
G MT3 metallothionein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16854967 NCBI chr16:36,875,919...36,877,558
Ensembl chr16:56,007,922...56,028,093 		JBrowse link
G MTHFR methylenetetrahydrofolate reductase susceptibility
no_association		 ISO DNA:transversion:cds:g.1298A>C (human)
DNA:transition, transversion, haplotype:cds:g.677C>T, g.1298A>C (human)
protein:missense mutation:cds:p.A222V (human)
DNA:transition:cds:g.677C>T (human)
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:17311259 PMID:19837268 PMID:20146887 PMID:22126575 PMID:22747749 RGD:6893457 RGD:6893516 RGD:6893521 RGD:6893597 NCBI chr 1:10,548,196...10,568,174
Ensembl chr 1:11,766,334...11,785,419 		JBrowse link
G MTOR mechanistic target of rapamycin kinase treatment ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:19261747 PMID:36115647 RGD:10040979 NCBI chr 1:9,871,700...10,028,704
Ensembl chr 1:11,093,765...11,249,841 		JBrowse link
G MTR 5-methyltetrahydrofolate-homocysteine methyltransferase susceptibility ISO DNA:polymorphism: :2756A>G(human) RGD PMID:19837268 RGD:6893521 NCBI chr 1:212,353,195...212,463,304
Ensembl chr 1:217,358,050...217,460,946 		JBrowse link
G MUC1 mucin 1, cell surface associated ISO protein:increased expression:serum: RGD PMID:10468735 RGD:7245967 NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850 		JBrowse link
G MUC5B mucin 5B, oligomeric mucus/gel-forming ISO DNA:repeats RGD PMID:19191526 RGD:7349339
G MYC MYC proto-oncogene, bHLH transcription factor disease_progression
susceptibility		 ISO protein:decreased expression:urinary bladder urothelium (human)
CTD Direct Evidence: marker/mechanism
DNA:snp, haplotype:enhancer:g.-30772G>T rs9642880 (human)		 RGD
CTD		 PMID:2228319 PMID:20939013 PMID:22028816 PMID:23284801 RGD:7207401 RGD:7207418 RGD:7207427 NCBI chr 8:124,387,561...124,393,551
Ensembl chr 8:127,131,512...127,136,863 		JBrowse link
G NAT1 N-acetyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16003747 NCBI chr 8:17,425,852...17,439,684
Ensembl chr 8:14,386,481...14,392,462 		JBrowse link
G NAT2 N-acetyltransferase 2 susceptibility ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:10022756 PMID:15717312 PMID:16327307 PMID:18505952 PMID:20972438 More... RGD:8552670 NCBI chr 8:17,606,445...17,623,397
Ensembl chr 8:14,575,455...14,576,327 		JBrowse link
G NCAN neurocan ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr19:18,650,522...18,690,882
Ensembl chr19:19,657,766...19,691,998 		JBrowse link
G NCOR1 nuclear receptor corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21822268 NCBI chr17:34,934,452...35,121,195 JBrowse link
G NCSTN nicastrin ISO OMIM:109800 MouseDO NCBI chr 1:135,697,592...135,713,293
Ensembl chr 1:139,618,229...139,633,911 		JBrowse link
G NECTIN2 nectin cell adhesion molecule 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29321541 NCBI chr19:41,794,037...41,837,047
Ensembl chr19:50,399,668...50,443,024 		JBrowse link
G NF1 neurofibromin 1 ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:8069310 PMID:10090487 PMID:10712197 PMID:10862084 PMID:10980545 More... NCBI chr17:25,425,081...25,703,689
Ensembl chr17:26,160,855...26,439,295 		JBrowse link
G NME1 NME/NM23 nucleoside diphosphate kinase 1 ISO mRNA:increased expression:urinary bladder RGD PMID:7614395 RGD:2299071 NCBI chr17:45,243,588...45,252,135
Ensembl chr17:50,113,622...50,131,636 		JBrowse link
G NME2 NME/NM23 nucleoside diphosphate kinase 2 ISO mRNA:increased expression:urinary bladder RGD PMID:7614395 RGD:2299071 NCBI chr17:45,255,982...45,261,541 JBrowse link
G NOS3 nitric oxide synthase 3 ISO protein:increased expression:urinary bladder RGD PMID:10475345 RGD:2292089 NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 treatment ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:8631603 PMID:21213404 RGD:10401939 NCBI chr16:50,090,696...50,106,495
Ensembl chr16:69,470,288...69,489,731 		JBrowse link
G NRSN1 neurensin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 6:23,953,574...23,974,797
Ensembl chr 6:24,288,702...24,313,372 		JBrowse link
G PABPC1 poly(A) binding protein cytoplasmic 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25783786 NCBI chr 8:97,346,433...97,365,628
Ensembl chr 8:99,518,347...99,537,614 		JBrowse link
G PHB1 prohibitin 1 ISO mRNA:increased expression:urinary bladder RGD PMID:8062216 RGD:2292407 NCBI chr17:8,189,555...8,200,491
Ensembl chr17:8,175,968...8,186,790 		JBrowse link
G PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar NCBI chr 3:176,182,765...176,272,024
Ensembl chr 3:184,355,785...184,441,977 		JBrowse link
G PIP5K1A phosphatidylinositol-4-phosphate 5-kinase type 1 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:34755307 NCBI chr 1:126,547,793...126,598,618
Ensembl chr 1:130,195,974...130,246,198 		JBrowse link
G PLAU plasminogen activator, urokinase treatment ISO protein:increased expression:urinary bladder (human)
DNA:snp:3' utr:g.4065C>T (human)		 RGD PMID:16825821 PMID:18336603 PMID:19010488 RGD:4144867 RGD:7241144 RGD:7241213 NCBI chr10:70,433,340...70,441,569
Ensembl chr10:73,105,895...73,113,136 		JBrowse link
G PLK1 polo like kinase 1 severity ISO RGD PMID:15761500 PMID:16837776 RGD:2299938 RGD:2299940 NCBI chr16:14,420,972...14,432,821
Ensembl chr16:23,928,773...23,940,779 		JBrowse link
G PMF1 polyamine modulated factor 1 disease_progression ISO RGD PMID:19088041 RGD:30296651 NCBI chr 1:131,556,843...131,583,180 JBrowse link
G PMS2 PMS1 homolog 2, mismatch repair system component susceptibility ISO DNA:SNP: :rs6463524 (human) RGD PMID:19692168 RGD:2315025 NCBI chr 7:7,433,031...7,459,560
Ensembl chr 7:6,167,403...6,202,984 		JBrowse link
G POLB DNA polymerase beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:8631603 NCBI chr 8:41,582,370...41,615,950
Ensembl chr 8:39,026,991...39,060,464 		JBrowse link
G PON1 paraoxonase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35764155 NCBI chr 7:87,253,476...87,279,650
Ensembl chr 7:100,841,286...100,867,493 		JBrowse link
G PPARG peroxisome proliferator activated receptor gamma ISO protein:decreased expression:urinary bladder RGD PMID:18712722 RGD:2301870 NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060 		JBrowse link
G PPP3CC protein phosphatase 3 catalytic subunit gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:29275364 NCBI chr 8:21,690,598...21,791,335
Ensembl chr 8:18,629,261...18,729,995 		JBrowse link
G PRDM2 PR/SET domain 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 1:12,838,201...12,963,735
Ensembl chr 1:13,853,895...13,961,610
Ensembl chr 1:13,853,895...13,961,610 		JBrowse link
G PRKCA protein kinase C alpha severity
disease_progression		 ISO protein:increased expression:urinary bladder
protein:altered localization:urinary bladder		 RGD PMID:15922420 PMID:16008942 RGD:2292455 RGD:2298669 NCBI chr17:60,246,485...60,747,158
Ensembl chr17:65,454,907...65,947,903 		JBrowse link
G PRSS3 serine protease 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15987713 NCBI chr 9:33,589,522...33,637,991
Ensembl chr 9:34,401,323...34,449,666 		JBrowse link
G PSCA prostate stem cell antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:19648920 PMID:20083643 NCBI chr 8:139,384,002...139,394,993
Ensembl chr 8:142,435,849...142,438,401 		JBrowse link
G PSMB2 proteasome 20S subunit beta 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 1:34,869,524...34,911,852
Ensembl chr 1:36,046,963...36,090,294 		JBrowse link
G PTEN phosphatase and tensin homolog disease_progression ISO protein:decreased expression:urinary bladder
ClinVar Annotator: match by term: Malignant tumor of urinary bladder		 RGD
ClinVar		 PMID:9140396 PMID:9256433 PMID:9735393 PMID:9811831 PMID:10051603 More... RGD:2291891 NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 disease_progression
susceptibility		 ISO CTD Direct Evidence: marker/mechanism
DNA:SNP:3' utr:837T>C (human)		 RGD
CTD		 PMID:10582676 PMID:10873095 PMID:12442003 PMID:12664575 PMID:16098373 More... RGD:2300127 RGD:2300200 RGD:5508302 NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519 		JBrowse link
G RAB27A RAB27A, member RAS oncogene family ISO CTD Direct Evidence: marker/mechanism CTD PMID:34291859 NCBI chr15:34,174,491...34,263,045
Ensembl chr15:52,498,202...52,529,984 		JBrowse link
G RAB27B RAB27B, member RAS oncogene family ISO CTD Direct Evidence: marker/mechanism CTD PMID:34291859 NCBI chr18:48,099,912...48,274,416
Ensembl chr18:51,542,842...51,604,061 		JBrowse link
G RALBP1 ralA binding protein 1 ISO mRNA, protein:increased expression:urinary bladder RGD PMID:17606711 RGD:2324917 NCBI chr18:4,747,555...4,810,710
Ensembl chr18:7,028,188...7,090,934 		JBrowse link
G RALGPS1 Ral GEF with PH domain and SH3 binding motif 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr 9:98,033,100...98,342,582
Ensembl chr 9:126,689,557...126,992,628 		JBrowse link
G RASSF1 Ras association domain family member 1 ISO DNA:hypermethylation
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:15987713 PMID:18702824 RGD:2299860 NCBI chr 3:50,255,897...50,267,042
Ensembl chr 3:51,491,548...51,502,392 		JBrowse link
G RB1 RB transcriptional corepressor 1 disease_progression ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder OMIM
ClinVar
RGD		 PMID:1352883 PMID:2181449 PMID:2601691 PMID:7704558 PMID:8651278 More... RGD:2299888 NCBI chr13:29,453,872...29,624,665
Ensembl chr13:48,155,795...48,324,575 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit disease_progression ISO RGD PMID:18089718 PMID:18188593 RGD:2293094 RGD:2298753 NCBI chr11:61,012,839...61,022,225
Ensembl chr11:64,347,859...64,356,868 		JBrowse link
G RETN resistin ISO protein:increased expression:urine RGD PMID:18373357 RGD:7207154 NCBI chr19:6,958,536...6,960,032
Ensembl chr19:7,812,942...7,814,909 		JBrowse link
G RHOA ras homolog family member A disease_progression ISO protein:increased expression:urinary bladder
CTD Direct Evidence: marker/mechanism		 RGD
CTD		 PMID:12855641 PMID:19896475 RGD:2298872 NCBI chr 3:49,282,009...49,339,887 JBrowse link
G RRM2 ribonucleotide reductase regulatory subunit M2 ISO mRNA:increased expression:bladder (rat)
mRNA:increased expression:bladder (mouse)
mRNA:increased expression:bladder (human)		 RGD PMID:21139803 RGD:5133688 NCBI chr2A:10,119,508...10,128,318
Ensembl chr2A:10,275,598...10,284,640 		JBrowse link
G RUNX3 RUNX family transcription factor 3 ISO DNA:promoter:aberrant methylation RGD PMID:16230397 RGD:2302553 NCBI chr 1:24,097,321...24,164,065
Ensembl chr 1:25,073,134...25,137,335 		JBrowse link
G S100A8 S100 calcium binding protein A8 ISO mRNA:increased expression:urinary bladder RGD PMID:17970044 RGD:2316906 NCBI chr 1:128,741,378...128,742,520
Ensembl chr 1:132,370,435...132,371,591 		JBrowse link
G S100A9 S100 calcium binding protein A9 ISO mRNA:increased expression:urinary bladder RGD PMID:17970044 RGD:2316906 NCBI chr 1:128,709,175...128,712,461
Ensembl chr 1:132,338,246...132,341,497 		JBrowse link
G S100B S100 calcium binding protein B ISO mRNA:decreased expression:urinary bladder urothelium
mRNA:increased expression:urinary bladder urothelium		 RGD PMID:17970044 RGD:2316906 NCBI chr21:33,063,845...33,070,073
Ensembl chr21:46,197,750...46,203,953 		JBrowse link
G SERPINE1 serpin family E member 1 ISO RGD PMID:19010488 RGD:4144867 NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450 		JBrowse link
G SFN stratifin disease_progression ISO protein:increased expression:urothelium (human) RGD PMID:17645415 RGD:2299928 NCBI chr 1:26,126,212...26,127,761
Ensembl chr 1:27,182,834...27,183,580 		JBrowse link
G SLC11A1 solute carrier family 11 member 1 disease_progression ISO DNA:repeat, polymorphism:promoter, cds:p.D543N (human) RGD PMID:16516037 RGD:5684951 NCBI chr2B:105,640,613...105,655,524
Ensembl chr2B:224,238,284...224,252,941 		JBrowse link
G SLC12A7 solute carrier family 12 member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 Ensembl chr 5:1,094,769...1,147,759 JBrowse link
G SLC19A1 solute carrier family 19 member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21760912 NCBI chr21:31,836,774...31,883,829
Ensembl chr21:45,090,595...45,134,752 		JBrowse link
G SMAD2 SMAD family member 2 ISO RGD PMID:15548366 RGD:2299964 NCBI chr18:41,213,001...41,309,902
Ensembl chr18:44,580,905...44,668,530 		JBrowse link
G SMAD4 SMAD family member 4 ISO protein:decreased expression:urinary bladder RGD PMID:11783019 RGD:2299972 NCBI chr18:44,402,112...44,456,779
Ensembl chr18:47,764,568...47,797,359 		JBrowse link
G SMC1A structural maintenance of chromosomes 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr  X:45,576,100...45,637,314
Ensembl chr  X:53,697,154...53,745,636 		JBrowse link
G SMC1B structural maintenance of chromosomes 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121791 NCBI chr22:26,229,904...26,299,559
Ensembl chr22:44,410,118...44,479,513 		JBrowse link
G SOCS1 suppressor of cytokine signaling 1 disease_progression ISO DNA:hypermethylation:promoter RGD PMID:16242928 PMID:17522834 RGD:2298903 RGD:2298906 NCBI chr16:10,196,432...10,198,205 JBrowse link
G SOD1 superoxide dismutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35764155 NCBI chr21:18,029,831...18,037,526 JBrowse link
G SOD2 superoxide dismutase 2 ISO CTD Direct Evidence: marker/mechanism RGD
CTD		 PMID:14729580 PMID:17974967 PMID:18930813 RGD:7175539 NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960 		JBrowse link
G SOX2 SRY-box transcription factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29396848 NCBI chr 3:178,744,881...178,747,392
Ensembl chr 3:186,922,705...186,923,662 		JBrowse link
G SOX4 SRY-box transcription factor 4 ISO RGD PMID:16585165 RGD:1581304 NCBI chr 6:21,422,846...21,427,779 JBrowse link
G SPARC secreted protein acidic and cysteine rich disease_progression ISO RGD PMID:11696817 PMID:17149610 RGD:2300021 RGD:2300024 NCBI chr 5:147,087,903...147,112,466
Ensembl chr 5:153,090,181...153,115,750 		JBrowse link
G SPINK1 serine peptidase inhibitor Kazal type 1 disease_progression ISO mRNA, protein:decreased expression:urinary bladder RGD PMID:16327984 RGD:2300384 NCBI chr 5:143,273,137...143,287,745 JBrowse link
G SPP1 secreted phosphoprotein 1 ISO RGD PMID:21483670 RGD:6903265 NCBI chr 4:80,263,711...80,271,466
Ensembl chr 4:90,988,200...90,995,935 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11723127 PMID:17093206 NCBI chr20:33,667,614...33,727,126
Ensembl chr20:34,822,271...34,839,634 		JBrowse link
G SRSF9 serine and arginine rich splicing factor 9 ISO mRNA:increased expression:urinary bladder epithelium (human) RGD PMID:22178073 RGD:11040443 NCBI chr12:118,043,325...118,052,107
Ensembl chr12:121,417,557...121,425,708 		JBrowse link
G STAG2 STAG2 cohesin complex component ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121789 PMID:24121791 PMID:24121792 NCBI chr  X:113,150,853...113,293,395
Ensembl chr  X:123,389,162...123,472,474 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:36115647 NCBI chr17:14,928,689...15,003,644
Ensembl chr17:15,152,358...15,227,067 		JBrowse link
G TACC3 transforming acidic coiled-coil containing protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24121792 NCBI chr 4:1,858,595...1,882,727
Ensembl chr 4:1,772,836...1,796,019 		JBrowse link
G TERT telomerase reverse transcriptase ISO ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:20871597 PMID:22037553 PMID:23066086 PMID:23348503 PMID:23535731 More... Ensembl chr 5:1,300,960...1,338,872 JBrowse link
G TFF1 trefoil factor 1 ISO protein:increased expression:urinary bladder RGD PMID:18283638 RGD:2291996 NCBI chr21:28,669,323...28,673,556
Ensembl chr21:41,988,039...41,992,270 		JBrowse link
G TFRC transferrin receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:16904380 NCBI chr 3:193,384,817...193,417,532
Ensembl chr 3:203,333,953...203,373,998 		JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 ISO RGD PMID:9363992 RGD:2302036 NCBI chr 9:70,195,007...70,243,514
Ensembl chr 9:98,332,739...98,362,748 		JBrowse link
G THBS1 thrombospondin 1 severity ISO protein:decreased expression:bladder RGD PMID:20299037 RGD:13602099 NCBI chr15:18,521,802...18,538,172
Ensembl chr15:36,776,756...36,793,170 		JBrowse link
G TIMP2 TIMP metallopeptidase inhibitor 2 disease_progression ISO CTD Direct Evidence: marker/mechanism
protein:decreased expression:serum		 CTD
RGD		 PMID:17374529 PMID:17466450 PMID:30548095 RGD:2290395 RGD:2298521 NCBI chr17:72,928,692...73,001,892
Ensembl chr17:78,476,807...78,495,649 		JBrowse link
G TIMP3 TIMP metallopeptidase inhibitor 3 ISO DNA:hypermethylation:promoter RGD PMID:18082200 RGD:2290411 NCBI chr22:13,811,297...13,872,799
Ensembl chr22:31,662,562...31,723,964 		JBrowse link
G TLR2 toll like receptor 2 ISO DNA:deletion:promoter:−196_−174del (human) RGD PMID:23142523 RGD:7207893 NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331 		JBrowse link
G TLR4 toll like receptor 4 treatment ISO RGD PMID:19788935 RGD:7240556 NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711 		JBrowse link
G TMEFF2 transmembrane protein with EGF like and two follistatin like domains 2 ISO DNA:hypermethylation:promoter RGD PMID:16234815 RGD:2290489 NCBI chr2B:79,242,825...79,489,113
Ensembl chr2B:197,158,689...197,396,254 		JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: therapeutic CTD PMID:1674182 NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381 		JBrowse link
G TNFRSF10A TNF receptor superfamily member 10a ISO DNA:missense mutation:cds:p.E228A (c.683A>C) (human) RGD PMID:16217763 RGD:11038717 NCBI chr 8:22,440,502...22,476,790
Ensembl chr 8:19,378,547...19,414,724 		JBrowse link
G TOP2A DNA topoisomerase II alpha disease_progression ISO RGD PMID:19913893 RGD:2315121 NCBI chr17:16,872,169...16,901,605
Ensembl chr17:17,097,778...17,126,207 		JBrowse link
G TP53 tumor protein p53 disease_progression ISO protein:increased expression:urinary bladder
ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder		 RGD
ClinVar		 PMID:224644 PMID:1565143 PMID:1591732 PMID:1631151 PMID:1683921 More... RGD:2290536 NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120 		JBrowse link
G TP63 tumor protein p63 disease_progression ISO RGD PMID:19690775 RGD:2315430 NCBI chr 3:186,651,879...186,918,300
Ensembl chr 3:195,199,167...195,474,104 		JBrowse link
G TP73 tumor protein p73 disease_progression ISO mRNA:increased expression:urinary bladder RGD PMID:10383132 RGD:2291836 NCBI chr 1:2,323,399...2,405,295
Ensembl chr 1:3,476,064...3,529,206 		JBrowse link
G TRPV1 transient receptor potential cation channel subfamily V member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19502594 NCBI chr17:3,612,781...3,658,608
Ensembl chr17:3,609,952...3,637,579 		JBrowse link
G TSC1 TSC complex subunit 1 ISO ClinVar Annotator: match by term: Bladder cancer | ClinVar Annotator: match by term: Malignant tumor of urinary bladder ClinVar PMID:9242607 PMID:9328481 PMID:9803264 PMID:9863590 PMID:9924605 More... NCBI chr 9:104,007,708...104,060,938
Ensembl chr 9:132,638,003...132,675,759 		JBrowse link
G TYMP thymidine phosphorylase disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:11103787 PMID:15841086 PMID:16937303 RGD:2293716 NCBI chr22:30,772,088...30,776,618 JBrowse link
G TYMS thymidylate synthetase ISO RGD PMID:18463958 RGD:2317413 NCBI chr18:13,653,085...13,668,478
Ensembl chr18:17,295,182...17,310,320 		JBrowse link
G UBE2I ubiquitin conjugating enzyme E2 I ISO radiation-induced dysplasia and carcinoma in situ; protein:increased expression:bladder urothelium:increased in Chernobyl victims vs controls from uncontaminated areas of the Ukraine (p<0.001) RGD PMID:16407042 RGD:2301343 Ensembl chr16:1,367,288...1,382,575 JBrowse link
G USP7 ubiquitin specific peptidase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr16:7,825,332...7,895,095
Ensembl chr16:9,065,858...9,106,146 		JBrowse link
G VEGFA vascular endothelial growth factor A ISO mRNA:increased expression:bladder RGD PMID:22895562 RGD:13605607 NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353 		JBrowse link
G VEGFC vascular endothelial growth factor C disease_progression ISO RGD PMID:17094484 RGD:2315482 NCBI chr 4:168,870,941...168,999,160
Ensembl chr 4:181,104,737...181,236,030 		JBrowse link
G VEGFD vascular endothelial growth factor D disease_progression ISO RGD PMID:17970053 RGD:2315479 NCBI chr  X:7,972,227...8,011,263
Ensembl chr  X:15,254,945...15,293,704 		JBrowse link
G VHL von Hippel-Lindau tumor suppressor ISO mRNA:decreased expression:urinary bladder RGD PMID:19399409 RGD:2325183 NCBI chr 3:10,077,630...10,089,499
Ensembl chr 3:10,430,143...10,440,234 		JBrowse link
G VWA3A von Willebrand factor A domain containing 3A ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr16:16,575,765...16,640,697
Ensembl chr16:22,403,518...22,468,186 		JBrowse link
G WIF1 WNT inhibitory factor 1 disease_progression ISO DNA:hypermethylation:promoter
protein:decreased expression:urinary bladder		 RGD PMID:14517837 PMID:18325051 RGD:2291868 RGD:727214 NCBI chr12:23,795,280...23,866,666
Ensembl chr12:24,299,351...24,370,807 		JBrowse link
G WNT7B Wnt family member 7B ISO mRNA:increased expression:superficial tumors vs normal bladder tissue (p=0.002) or invasive tumors (p=0.003) RGD PMID:9461004 RGD:2299932 Ensembl chr22:44,988,647...45,044,841 JBrowse link
G XDH xanthine dehydrogenase ISO protein:decreased activity:urinary bladder RGD PMID:20087949 RGD:7247647 NCBI chr2A:31,356,011...31,435,111
Ensembl chr2A:31,425,183...31,504,455 		JBrowse link
G XRCC1 X-ray repair cross complementing 1 susceptibility
no_association		 ISO DNA:polymorphism: :p.R399Q
DNA:SNP: p.R399Q (human)
DNA:polymorphisms: :multiple		 RGD PMID:17425776 PMID:18272472 PMID:18765423 RGD:150530493 RGD:2302568 RGD:2302572 NCBI chr19:40,485,052...40,522,188
Ensembl chr19:49,094,014...49,125,520 		JBrowse link
G YJEFN3 YjeF N-terminal domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26039340 NCBI chr19:18,966,788...18,976,052
Ensembl chr19:19,964,456...19,973,200 		JBrowse link
G ZNF609 zinc finger protein 609 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35567596 NCBI chr15:43,405,805...43,628,201
Ensembl chr15:61,735,706...61,912,212 		JBrowse link
bladder carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PMF1 polyamine modulated factor 1 disease_progression ISO RGD PMID:22682992 RGD:30296649 NCBI chr 1:131,556,843...131,583,180 JBrowse link
bladder squamous cell carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTEN phosphatase and tensin homolog disease_progression ISO associated with schistosomiasis;protein:decreased expression:urothelium (human) RGD PMID:26916953 RGD:127285612 NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605 		JBrowse link
bladder urothelial carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACTL7A actin like 7A ISO RGD PMID:29058301 RGD:13831338 NCBI chr 9:80,014,898...80,016,379
Ensembl chr 9:108,188,166...108,189,473 		JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 disease_progression ISO mRNA:increased expression:urinary bladder (human) RGD PMID:31964418 RGD:153344516 NCBI chr17:72,292,332...72,303,493
Ensembl chr17:77,842,724...77,854,159 		JBrowse link
G BIRC7 baculoviral IAP repeat containing 7 disease_progression ISO mRNA:increased expression:urinary bladder (human) RGD PMID:31964418 RGD:153344516 NCBI chr20:59,618,530...59,623,612
Ensembl chr20:61,157,302...61,161,932 		JBrowse link
G CA2 carbonic anhydrase 2 severity ISO protein:increased expression:bladder epithelial cell RGD PMID:28004470 RGD:408426005 NCBI chr 8:81,991,037...82,009,010
Ensembl chr 8:83,597,440...83,632,580 		JBrowse link
G FGFR3 fibroblast growth factor receptor 3 severity ISO protein:increased expression:urothelial cells (human) RGD PMID:28507621 RGD:38500205 NCBI chr 4:1,933,172...1,948,742
Ensembl chr 4:1,843,774...1,861,692 		JBrowse link
G KDM6A lysine demethylase 6A susceptibility ISO associated with upper tract urothelial carcinoma; DNA:mutations:multiple: (human) RGD PMID:30352907 RGD:150429735 NCBI chr  X:37,313,000...37,548,630
Ensembl chr  X:45,127,382...45,362,029 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  disease 15834
    disease of cellular proliferation 7466
      cancer 5472
        organ system cancer 5230
          urinary system cancer 635
            urinary bladder cancer 288
              Urachal Adenocarcinoma 0
              bladder carcinoma + 8
              bladder dome cancer 0
              bladder lateral wall cancer 0
              bladder lymphoma 0
              bladder neck cancer 0
              bladder sarcoma 0
              bladder sarcomatoid transitional cell carcinoma 0
              bladder trigone cancer 0
              urachus cancer + 0
              ureteric orifice cancer 0
              urinary bladder anterior wall cancer 0
              urinary bladder posterior wall cancer 0
Path 2
Term Annotations click to browse term
  disease 15834
    disease of cellular proliferation 7466
      Neoplasms by Site 6922
        Urogenital Neoplasms 2285
          Urologic Neoplasms 684
            urinary system cancer 635
              urinary bladder cancer 288
                Urachal Adenocarcinoma 0
                bladder carcinoma + 8
                bladder dome cancer 0
                bladder lateral wall cancer 0
                bladder lymphoma 0
                bladder neck cancer 0
                bladder sarcoma 0
                bladder sarcomatoid transitional cell carcinoma 0
                bladder trigone cancer 0
                urachus cancer + 0
                ureteric orifice cancer 0
                urinary bladder anterior wall cancer 0
                urinary bladder posterior wall cancer 0
paths to the root